Lataa...
Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
BACKGROUND: Rituximab has been used successfully in the recent years for treatment of neuromyelitis optica spectrum disorders (NMOSD). However, a uniform treatment protocol for maintenance therapy and the best interval for evaluation and retreatment have not been postulated. We evaluated the efficac...
Tallennettuna:
| Julkaisussa: | Caspian J Intern Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Babol University of Medical Sciences
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265520/ https://ncbi.nlm.nih.gov/pubmed/32509243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22088/cjim.11.2.155 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|